Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 4
2006 6
2007 1
2008 2
2009 2
2010 1
2011 2
2013 1
2014 1
2015 3
2016 1
2019 2
2020 2
2021 3
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
[Domestic Malaria Cases in Kayseri Province].
Türe Z, Yıldız O, Yaman O, Kalın Ünüvar G, Aygen B. Türe Z, et al. Among authors: yildiz o. Mikrobiyol Bul. 2023 Apr;57(2):307-316. doi: 10.5578/mb.20239922. Mikrobiyol Bul. 2023. PMID: 37067215 Free article. Turkish.
Actinomycoses and Nocardia pulmonary infections.
Yildiz O, Doganay M. Yildiz O, et al. Curr Opin Pulm Med. 2006 May;12(3):228-34. doi: 10.1097/01.mcp.0000219273.57933.48. Curr Opin Pulm Med. 2006. PMID: 16582679 Review.
Physiological-dose steroid therapy in sepsis [ISRCTN36253388].
Yildiz O, Doganay M, Aygen B, Güven M, Keleştimur F, Tutuû A. Yildiz O, et al. Crit Care. 2002 Jun;6(3):251-9. doi: 10.1186/cc1498. Epub 2002 Apr 19. Crit Care. 2002. PMID: 12133187 Free PMC article. Clinical Trial.
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.
Tanriover MD, Aydin OA, Guner R, Yildiz O, Celik I, Doganay HL, Kose S, Akhan S, Akalin EH, Sezer Z, Ozdarendeli A, Unal S, On Behalf Of The Turkovac Study Group. Tanriover MD, et al. Among authors: yildiz o. Vaccines (Basel). 2022 Nov 4;10(11):1865. doi: 10.3390/vaccines10111865. Vaccines (Basel). 2022. PMID: 36366373 Free PMC article.
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
Demirtürk N, Aygen B, Çelik İ, Mıstık R, Akhan S, Barut Ş, Ural O, Batırel A, Şimşek F, Ersöz G, İnan D, Kınıklı S, Türker N, Bilgin H, Gürbüz Y, Tülek N, Tarakçı H, Yıldız O, Türkoğlu E, Kamalak Güzel D, Şimşek S, Tuna N, Aktuğ Demir N, Çağatay A, Çetinkaya RA, Karakeçili F, Hakyemez İN, Tuncer Ertem G, Örmen B, Korkmaz P, Yıldız U, Kuruüzüm Z, Şener A, Arslan Özel S, Öztürk S, Suer K, Çelen MK, Konya P, Asan A, Saltoğlu N, Doğan N. Demirtürk N, et al. Among authors: yildiz o. Turk J Gastroenterol. 2021 Feb;32(2):155-163. doi: 10.5152/tjg.2020.19569. Turk J Gastroenterol. 2021. PMID: 33960939 Free PMC article.
Deciphering the host genetic factors conferring susceptibility to severe COVID-19 using exome sequencing.
Uslu K, Ozcelik F, Zararsiz G, Eldem V, Cephe A, Sahin IO, Yuksel RC, Sipahioglu H, Ozer Simsek Z, Baspinar O, Akalin H, Simsek Y, Gundogan K, Tutar N, Karayol Akin A, Ozkul Y, Yildiz O, Dundar M. Uslu K, et al. Among authors: yildiz o. Genes Immun. 2024 Feb;25(1):14-42. doi: 10.1038/s41435-023-00232-9. Epub 2023 Dec 20. Genes Immun. 2024. PMID: 38123822
39 results